Down Staging of Cirrhosis in All Cirrhotic Patients With HCV Genotype 3-a Infection, Treated With 12-Weeks Triple Therapy, Including Sofosbuvir, Daclatasvir and Ribavirin. mfm 2024, 29 (3).